Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of metabolic dysfunction-associated steatotic liver disease and of its genetics on kidney function in childhood obesity. | Int J Obes (Lond) | 2025 | 39521922 | PubTator, text mining | PubMed |
| Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations. | Clin Mol Hepatol | 2025 | 39439408 | PubTator, text mining | PubMed |
| Impact of PNPLA3 I148M on Clinical Outcomes in Patients With MASLD. | Liver Int | 2025 | 39412170 | PubTator, text mining | PubMed |
| Role of PNPLA3 in Hepatic Stellate Cells and Hepatic Cellular Crosstalk. | Liver Int | 2025 | 39394864 | PubTator, text mining | PubMed |
| PNPLA3 rs738409, environmental factors and liver-related mortality in the US population. | J Hepatol | 2025 | 39389267 | PubTator, text mining | PubMed |
| Decoding the Knacks of Ellagitannin Lead Compounds to Treat Nonalcoholic Fatty Liver Disease using Computer-aided Drug Designing. | Curr Comput Aided Drug Des | 2025 | 39377405 | PubTator, text mining | PubMed |
| Clinical Utility of Genetic Variants in PNPLA3 and TM6SF2 to Predict Liver-Related Events in Metabolic Dysfunction-Associated Steatotic Liver Disease. | Liver Int | 2025 | 39373247 | PubTator, text mining | PubMed |
| Global Epidemiological Impact of PNPLA3 I148M on Liver Disease. | Liver Int | 2025 | 39373119 | PubTator, text mining | PubMed |
| Integrating PNPLA3 into clinical risk prediction. | Liver Int | 2025 | 39282715 | PubTator, text mining | PubMed |
| Sex-specific effects of PNPLA3 I148M. | Liver Int | 2025 | 39262132 | PubTator, text mining | PubMed |
PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD: Correspondence to editorial on "TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD". | Clin Mol Hepatol | 2025 | 39253745 | PubTator, text mining | PubMed |
| Association of PNPLA3 risk variant with steatotic liver disease among lean people with HIV mono-infection. | J Hepatol | 2025 | 39218226 | PubTator, text mining | PubMed |
| TM6SF2 and PNPLA3: A potential dynamic duo?: Editorial on "TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD". | Clin Mol Hepatol | 2025 | 39188231 | PubTator, text mining | PubMed |
| The effect of dulaglutide on glycated hemoglobin is associated with PNPLA3 Ι148Μ gene polymorphism in patients with type 2 diabetes mellitus. | Endocrine | 2025 | 39179734 | PubTator, text mining | PubMed |
| Precision medicine and nucleotide-based therapeutics to treat steatotic liver disease. | Clin Mol Hepatol | 2025 | 39103998 | PubTator, text mining | PubMed |
| Exome-wide association analysis identifies novel risk loci for alcohol-associated hepatitis. | Hepatology | 2025 | 39058584 | PubTator, text mining | PubMed |
| PNPLA3 variation and kidney disease. | Liver Int | 2025 | 38873992 | PubTator, text mining | PubMed |
| PNPLA3 Inhibition: Replacing One Evil With the Other? | J Clin Endocrinol Metab | 2025 | 38820113 | PubTator, text mining | PubMed |
| LDL-C and TC Mediate the Risk of PNPLA3 Inhibition in Cardiovascular Diseases. | J Clin Endocrinol Metab | 2025 | 38636099 | PubTator, text mining | PubMed |
| A genetic basis of mitochondrial DNAJA3 in nonalcoholic steatohepatitis-related hepatocellular carcinoma. | Hepatology | 2025 | 37870291 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=17